Hide Board Information

Show Board Information

Customers Bancorp Inc. CUBI.PRD

Board Mod: Add me as mod

Asst Mods:

Last Post: 02/09/2016 11:34:08 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Customers Bancorp Inc. (OTCMRKTS: CUBI.PRD) Stock Message Board

1. CUBI.PRD Company Profile

    

2. CUBI.PRD Time & Sales

    

3. CUBI.PRD Recent News

    

4. CUBI.PRD Filings

    

5. CUBI.PRD Financials

    

6. CUBI.PRD Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Customers Bancorp Inc. CUBI.PRD

Recent Articles

• Transforming DeFi: The Rise of Intelligent AI Superagents
• Strategic Resources' AGM Delivers Positive Results for Shareholders
• TriNet Declares Quarterly Dividend to Enhance Shareholder Value
• FMC Corporation Welcomes Anthony DiSilvestro to Board of Directors
• MSA Safety to Lead Discussion on Advanced Safety Technology
• Iconic Minneapolis Wells Fargo Center Acquired by Top Investors
• Carnegie Learning Celebrates Third Recognition on GSV 150 List
• Repare Therapeutics Shares Promising Data on New Cancer Treatment
• LeddarTech Secures Key Royalty Payment from Texas Instruments
• E2open to Release Third Quarter Financial Results Soon
• EPR Properties Announces Monthly and Quarterly Dividend Payouts
• Arby’s Unveils Thighsman Award with Joe Theismann's Support
• JPMorganChase Welcomes Michele G. Buck to Leadership Team
• Transforming Skincare: Ourself Unveils Revolutionary Delivery Tech
• Transforming IT Roles: Navigating Cybersecurity and Cloud Challenges
• ThriveDX Expands University Partnerships in Cybersecurity Training
• John Hancock's Fund Transition to Diversified Income Strategy
• Leadership Shift at Darling Ingredients Inc. Marks New Era
• John Hancock Funds Enhance Shareholder Value through Repurchase Plans
• CoolIT Systems Enhances Production to Meet AI Demand
• Commercial Metals Company Embraces Sustainability for 2024
• Canaan Inc. Strengthens Market Position with New Partnership
• Vir Biotechnology's New Breakthroughs in Hepatitis Delta Therapy
• Kuehn Law Advocates for Empire Petroleum Corp Investors
• Top Early Childhood Curriculum Innovator Earns GSV 150 Distinction
• Aurora Innovation Launches Cutting-Edge Lidar Facility
• Corcept Reveals Groundbreaking CATALYST Trial Results for Diabetes
• Lawrence (Liren) Chen Joins Arrow Electronics Board of Directors
• WD-40 Company Strengthens Leadership with New Chairman Appointment
• Moshe Gavrielov Joins Cadence's Board of Directors
• Boosting EV Infrastructure: EVgo Secures $1.25 Billion Loan
• Good Times Restaurants Sees Growth Amid Operational Change
• Scorpio Tankers Secures $500 Million Credit Facility to Boost Growth
• RH's Third Quarter Performance: Insights and Financial Overview
• Wabash Unveils Innovative Features for 2026 DuraPlate Dry Van
• McGrath RentCorp Announces New Quarterly Dividend Plans
• Costco Wholesale Achieves Record Sales and Income Growth
• Barings Corporate Investors Declares Dividends for Shareholders
• Tavia Acquisition Corp. Completes Successful IPO with Full Over-Allotment
• Arcosa, Inc. Announces Dividend and Share Buyback Plan Update
• Cherry Hill Mortgage Investment Corporation Announces Q4 2024 Dividends
• DHT Holdings Announces Strategic Sale of DHT Scandinavia
• Redwood Trust Boosts Dividend by 5.9% to Enhance Shareholder Value
• Portage Biotech's Nasdaq Listing Compliance Journey Ahead
• Equity Residential's Quarterly Dividends Announced for Shareholders
• Inventiva Announces Voting Outcomes from Recent Shareholder Meeting
• AG Growth International Declares Fourth Quarter Dividend for 2024
• Zoetis Announces Significant Dividend Increase for 2025
• Barings Participation Investors Declares Special Dividend Boost
• Editas Medicine's New Direction: Focusing on In Vivo Gene Editing